ManifestSeven Doubles Revenue, Targets Profitability
November 4, 2020
Ryan Allway November 4th, 2020 App, Exclusive, News, Top News ManifestSeven Holdings Corporation (CSE: MSVN) recently reported third-quarter financial results that showed a 96% increase in year-over-year revenue and continued advancement towards net profitability. In particular, quarterly revenue rose 64% to $4.7 million and an adjusted EBITDA loss that... Read more
Ryan Allway November 4th, 2020 App, Exclusive, Psychedelics, Top Story Most pharmaceutical and biotech investors are familiar with long commercialization timelines, but there are a few ways to shortcut the process. For example, the Food and Drug Administration provides Fast Track, Breakthrough Therapy, Accelerated Approval and Priority Review designations... Read more
How One Company Is Making Tryptamines & Cannabinoids Greener
October 23, 2020
Ryan Allway October 23rd, 2020 App, Exclusive, Psychedelics, Top Story Cannabinoids and tryptamines have the potential to treat a wide range of diseases, which has generated significant interest among pharmaceutical companies in accessing purified compounds. Unfortunately, these compounds are often created in agricultural or chemical synthesis processes that are... Read more
Ryan Allway October 20th, 2020 App, Exclusive, News, Top Story California has the world’s largest cannabis market with an estimated $12 billion in annual sales. While legal cannabis sales topped $3 billion last year, the state continues to struggle to meet high expectations with logistical and other challenges. ManifestSeven... Read more
Pure Extracts Secures Processing License from Health Canada
October 7, 2020
Ryan Allway October 7th, 2020 App, Exclusive, Top Story Canada’s cannabis industry has exploded in size over the past few years. With more cultivation coming online, the retail price of cannabis biomass has fallen to about $5 per gram (including taxes) during the first quarter. The legalization and consumer... Read more
Why Locations Matters in Cannabis
October 5, 2020
Ryan Allway October 5th, 2020 App, Exclusive, News, Top Story The global cannabis industry has projected to be worth $73.6 billion by 2027, according to Grand View Research, which represents a blistering 18.1% compound annual growth rate. While cannabis has historically been grown indoors, outdoor cultivation has become increasingly... Read more
Why Psychedelic Delivery Mechanisms Matter
October 2, 2020
Ryan Allway October 2nd, 2020 App, Exclusive, News, Psychedelics, Top News The psychedelics industry is poised to become a nearly $7 billion market by 2027, according to Data Bridge Market Research, driven by the potential to revolutionize the treatment of mental health disorders. While investors have many options in... Read more
Building a Cannabis Conglomerate
October 1, 2020
Ryan Allway October 1st, 2020 App, Exclusive, News, Top News Investors don’t have to look hard to find conglomerates in the alcoholic beverage industry—a close proxy for the recreational cannabis industry. AB InBev (NYSE: BUD) generates about $50 billion per year in sales with more than 400 beer brands... Read more
‘Amazon of Cannabis’ ManifestSeven Makes Its Debut on the CSE
October 1, 2020
Ryan Allway October 1st, 2020 App, Exclusive, News, Top Story ManifestSeven Holdings Corporation (CSE: MSVN) began trading on the Canadian Securities Exchange on Wednesday. With its reverse takeover complete and its listing on the CSE launched, the first integrated omnichannel platform for legal cannabis achieved a critical milestone and... Read more
MindLeap Health Enters into Fast-Growing Telehealth Market
September 29, 2020
Ryan Allway September 29th, 2020 App, Exclusive, Psychedelics, Top Story The COVID-19 pandemic has led to dramatic changes in healthcare. In addition to mobilizing a vaccine in record time, the pandemic could permanently alter the way that many people seek medical care, shifting from in-person to telehealth. These changes... Read more
